Recent human clinical trials on Nicotinamide Mononucleotide (NMN) have demonstrated its safety and potential effectiveness in combating age-related decline. NMN, a precursor to NAD+ which is crucial for cellular energy and repair, may help improve metabolism, enhance physical function, and slow down aspects of aging.
https://www.lifespan.io/news/human-clinical-trials-of-nmn-for-safety-and-effectiveness/